Himachal Pradesh high court restrains DRL from selling BI’s diabetic drug Jardiance

Dr Reddy’s on Thursday said Himachal Pradesh high court has issued an interim injunction restraining them from manufacturing and selling generic version of German drug maker Boehringer Ingelheim‘s (BI) diabetes drug Jardiance.

The drugmaker said it is reviewing legal options including filing an appeal against the court order.

Dr Reddy’s has launched copies of Jardiance (empagliflozin), which has valid patent in India until 2025. BI has sought restraining order on manufacture and sale of the drug.

Jardiance is top-selling drug for BI in India.

  • Related Posts

    Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

    Hyderabad: In a significant enforcement action against the illegal marketing of prescription medicines, the Drugs Control Administration (DCA), Telangana, seized Gabazen Tablets containing Gabapentin 300 mg in Hyderabad’s Malakpet area…

    Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

    Ahmedabad: Gujarat’s healthcare system is under intense scrutiny after official data revealed that more than 85,000 units of donated blood were discarded across the state due to storage lapses, expiry, logistical…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

    Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

    Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

    Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

    AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care

    AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care

    Nearly Three in Ten Products in Indian Local Markets Perceived as Counterfeit; Pharmaceuticals and FMCG among Worst-Affected Sectors: ASPA–CRISIL Intelligence Report

    Nearly Three in Ten Products in Indian Local Markets Perceived as Counterfeit; Pharmaceuticals and FMCG among Worst-Affected Sectors: ASPA–CRISIL Intelligence Report

    Culture reports reveal bacteria damaged cornea of five patients from Kuchaman

    Culture reports reveal bacteria damaged cornea of five patients from Kuchaman

    FSSAI prohibits Dabur from selling food products with ‘100%’ claims

    FSSAI prohibits Dabur from selling food products with ‘100%’ claims